Ritivel

Problem & Solution Report

Problem

• Regulatory submissions for clinical trials are slow, manual, and audit‑intensive. Creating Clinical Study Reports (CSRs) and Common Technical Document (CTD) modules can take weeks, with multiple rounds of review and strict traceability requirements from agencies such as the FDA and ICH.
• Companies face risk of non‑compliance, delayed market entry, and high operational costs due to the labor‑heavy nature of these documents.

Solution

• Ritivel offers an AI‑native regulatory platform that ingests protocol, statistical analysis plans, and raw trial data to generate CSRs, CTD Module 2 summaries, and literature sections in seconds.
• The platform provides word‑level traceability back to source documents, satisfying audit demands.
• It is deployed 100 % on‑premise, ensuring sensitive patient and trial data never leaves the client’s infrastructure.
• Modules include:
  • CSR Automation – end‑to‑end generation from protocol + SAP to final report.
  • CTD Automation – streamlined creation of Module 2 summaries and literature citations.
  • Regulatory Search – instant answers from FDA and ICH sources.
• By reducing authoring time from weeks to minutes, Ritivel cuts time‑to‑file, review cycles, and compliance risk while maintaining full reproducibility.

Market & Competitors Report

Market Overview

• The regulatory documentation market sits at the intersection of medical writing (≈ USD 5.6 B in 2026) and Regulatory Information Management software (≈ USD 2‑4 B by 2030). Growth is driven by increasing clinical‑trial activity, stricter regulatory scrutiny, and a push toward digital transformation.
• Trends include AI‑enabled automation, on‑premise data security, and traceability‑by‑design to meet FDA and ICH requirements.

AI‑Medical‑Writing / CSR Automation Competitors

• Yseop – offers clinical document automation with built‑in regulatory knowledge and traceability (source: https://yseop.com/solutions/life-sciences/clinical/).
• Clinion – provides GenAI‑driven CSR automation, claiming up to 70 % auto‑population of reports (source: https://www.clinion.com/csr-automation/).
• Narrativa – CSR Atlas automates report creation with data‑driven narratives and click‑through source tracing (source: https://www.narrativa.com/automation-of-clinical-study-reports/).
• Lexoro – automates CTD overview and summary generation (source: https://lexoro.ai/use-cases/automated-generation-of-overviews-and-summaries-for-ctd/).

Regulatory Information Management (RIM) Software Competitors

• Veeva Systems (Vault RIM)
• ArisGlobal (LifeSphere Regulatory)
• Ennov, Calyx, MasterControl, Rimsys, LORENZ Life Sciences Group, EXTEDO, PhlexGlobal – all listed in the Grandview Research RIM market report.

Competitive Positioning

• Ritivel’s differentiators: full on‑premise deployment, word‑level traceability, domain‑trained large language models, and a focus on speed (minutes vs. weeks).
• Competitors often provide cloud‑based solutions or less granular traceability, giving Ritivel a niche advantage for highly regulated, data‑sensitive customers.
• Market analysts (McKinsey) highlight the broader industry shift toward AI‑driven regulatory submissions, confirming the strategic relevance of Ritivel’s approach.

Founders and Background Report

Pavan Kalyan (PK) Tankala – Founder & CEO

• Formerly a researcher at Microsoft Research where he focused on advanced AI systems.
• Holds a BTech and MTech in Electrical Engineering & AI from IIT Bombay.
• Published research at top venues such as NeurIPS, ACL, and Interspeech.

Nirmit Arora – Founder & CTO

• Also came from Microsoft Research, working on safe, agentic AI systems.
• Shares the same IIT Bombay technical education background.

Gunin Gupta – Founder & COO/CBO

• Previously worked at AT Kearney, gaining experience in consulting and operations.
• Graduated with a Bachelor’s degree from IIT Bombay.

The trio combines deep AI research expertise with consulting and operational experience, positioning them to tackle complex regulatory documentation challenges. The YC profile confirms the founding year (2025), batch (Winter 2026), and a San Francisco location, while the company website’s About page lists the founders and their prior affiliations.